Table 2.
Characteristics associated with self-reported anti-HCV serostatus, 15–30-year-old injection drug users in five U.S. cities.
NOTE: All injection and alcohol use risk behaviors are within the past three months unless otherwise noted; p-values refer to chi-square test for differences between subjects who reported they were anti-HCV-positive, negative, or didn't know their serostatus.
Safe sources of syringes included needle exchanges, pharmacies and hospitals.


